1
-
3
of
3
results (0.2 seconds)
Sort By:
-
Session 015: Actuaries and Pharmaceutical Manufacturers: Friend or Foe?
Session 015: Actuaries and Pharmaceutical Manufacturers: Friend or Foe? Recently, actuaries have become more involved in formulary decisions due to high and variable pharmacy cost and utilization ...- Authors: Whitney Pratt, Jason Fehr, Karl J. Gregor
- Date: May 2019
- Competency: Strategic Insight and Integration
- Topics: Actuarial Profession>Professional development; Economics>Health economics
-
Session 108: Outcome Based Risk Sharing Arrangements – From Theory to Practice
Session 108: Outcome Based Risk Sharing Arrangements – From Theory to Practice The proposed session will introduce Outcome Based Risk Sharing Arrangements (“OBRSA”) between health insurance payers ...- Authors: Karl J. Gregor, Whitney Pratt, Jim Xun Jun Li
- Date: May 2019
- Competency: External Forces & Industry Knowledge
- Topics: Health & Disability>Health risks; Technology & Applications>Analytics and informatics
-
Session 133: Leveraging Real-World Data to Enhance Existing Actuarial Analytics and to Potentially Evolve Actuarial Methods and Value Drivers
Session 133: Leveraging Real-World Data to Enhance Existing Actuarial Analytics and to Potentially Evolve Actuarial Methods and Value Drivers Health care is a complex market with a wide variety ...- Authors: James Dolstad, Karl J. Gregor, Andrew Mackenzie, David L. Van Brunt
- Date: May 2019
- Competency: External Forces & Industry Knowledge
- Topics: Economics>Health economics; Health & Disability>Health insurance